Letter: promising results of Helicobacter pylori eradication with vonoprazan-based triple therapy after failure of proton pump inhibitor-based triple therapy

T Inaba¹, M Iwamuro^{2

3}, T Toyokawa⁴, H Okada^{5

6}

Affiliations

¹ Department of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
² Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. iwamuromasaya@yahoo.co.jp.
³ Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan. iwamuromasaya@yahoo.co.jp.
⁴ Department of Gastroenterology, Fukuyama Medical Center, Fukuyama, Japan.
⁵ Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
⁶ Department of Endoscopy, Okayama University Hospital, Okayama, Japan.

Comment

T Inaba et al. Aliment Pharmacol Ther. 2016 Jan.

. 2016 Jan;43(1):179-80.

doi: 10.1111/apt.13462.

T Inaba¹, M Iwamuro^{2

3}, T Toyokawa⁴, H Okada^{5

6}

¹ Department of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
² Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. iwamuromasaya@yahoo.co.jp.
³ Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan. iwamuromasaya@yahoo.co.jp.
⁴ Department of Gastroenterology, Fukuyama Medical Center, Fukuyama, Japan.
⁵ Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
⁶ Department of Endoscopy, Okayama University Hospital, Okayama, Japan.

No abstract available

Comment on

Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label cross-over study.
Sakurai Y, Mori Y, Okamoto H, Nishimura A, Komura E, Araki T, Shiramoto M. Sakurai Y, et al. Aliment Pharmacol Ther. 2015 Sep;42(6):719-30. doi: 10.1111/apt.13325. Epub 2015 Jul 21. Aliment Pharmacol Ther. 2015. PMID: 26193978 Clinical Trial.